Press

We are always pleased to hear from members of the press interested in what we’re doing at Acurable. The information and resources on this page are yours to use (please take note of our branding and trademark guidelines), or get in contact with us directly at press@acurable.com for a more in-depth discussion.

About Acurable

The company

  • Acurable is a fast growing MedTech start-up with offices in the UK and Spain.
  • Our mission is to understand human biosignals so well that nobody dies of a treatable condition ever again.

The technology

  • The first wearable medical device able to accurately diagnose and manage respiratory conditions in a non-invasive way.
  • Accurate: Clinically proven 5x more accurate than current solutions.
  • Easy to use: enabling home use without visiting the hospital.

Key facts

  • Founded in 2016 by Professor Esther Rodriguez-Villegas and Emilio Sanz Pereiras (founder bios).
  • Based on 10 years research at Imperial College London (more about our story).
  • Winner of XPrize in 2014, the most prestigious prize in the medical technology industry.
  • Clinically validated results published by top medical journal (BMJ Open).
  • First product focused on improving diagnosis of sleep apnoea (more about our products).
  • Raised £2.1m investment from Kindred Capital and Alma Mundi Ventures in 2017.

Media assets

Logo without icon (EPS + PNG)

Logo with icon (EPS + PNG)

Colours

White
#FFFFFF
R255 G255 B255
Dark grey
#2F2F2F
R47 G47 B47
Mustard yellow
#F3BA00
R243 G186 B0
Dark blue
#004366
R0 G67 B102

Images

Company spelling

When referencing our company brand and products in writing:

  • Acurable is always written as a single word with an uppercase A.
  • AcuPebbleTM is always written as a single word with an uppercase A and P, followed by the Trademarked symbol in superscript format (TM).
  • AcuCoreTM is always written as a single word with an uppercase A and C, followed by the Trademarked symbol in superscript format (TM).

Stay updated about the company news with our newsletter